Hyperfine Inc

Hyperfine Inc(HYPR)股票分析

$0.685

-0.059 (-8.65%)收盤時

Loading chart…
最高
0.755
開盤
0.751
成交量加權均價
0.70
成交量
826.77K
市值
68.77M
最低
0.670
成交金額
581.58K
企業價值/稅息折舊攤銷前利潤(TTM)
-0.87

Hyperfine, Inc. is a health technology company. The Company is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets.

AI 分析 of Hyperfine Inc (HYPR)

持有

Hyperfine Inc (HYPR) is currently priced at $0.7227, which is significantly below its 52-week high of $1.94, indicating potential upside. However, the RSI of 36.757 suggests the stock is currently oversold, and the company has a gross margin of 50.72%, indicating it can maintain profitability despite challenges. The main risk is the negative net income, which was -$9,298,000 in Q2 2026, showing ongoing financial struggles. Given these factors, while there is potential for recovery, the current financial instability suggests a hold rather than a buy at this time.

估值指標

Hyperfine Inc(HYPR)目前預期本益比為 0.00,5 年平均預期本益比為 -2.17。

預期本益比

嚴重高估
5 年均值 P/E
-2.17
目前P/E
0.00
高估
-1.13
低估
-3.20

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-0.86
目前EV/EBITDA
-0.87
高估
0.95
低估
-2.67

預期股價營收比

合理
5 年均值 P/S
7.65
目前P/S
2.96
高估
15.80
低估
-0.49

持有 HYPR 的大戶

A

Alphabet Inc.

+ 持有HYPR

+0.00%

3個月報酬率

事件時間軸

2026-10-22 (ET)

08:30:00

Hyperfine Receives CE Mark and UKCA Approval for Optive AI Software

2026-10-08 (ET)

12:30:00

Major Averages Decline as Oil Prices Surge

08:00:00

Hyperfine Expects Q3 2026 Net Cash Burn of Approximately $5.6M

08:00:00

Management Expects 2026 Revenue of $20M-$22M

2026-09-28 (ET)

08:30:00

Hyperfine Appoints Roots Pharmaceutical as Exclusive Distributor for Kuwait and UAE

資訊

HYPR 常見問題 —— 由 Alphio AI 解答

Hyperfine, Inc. is a health technology company. The Company is engaged in providing patient care globally through artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. Its Swoop Portable MR Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional magnetic resonance imaging (MRI) scanners. Its Swoop system is designed to transform brain MR for the patient, the clinician and the provider, enabling a highly differentiated experience for patients, timely imaging for clinicians, and favorable economics for hospital administrators. The Swoop system is a portable ULF MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. The Swoop system is FDA-cleared for brain imaging of patients of all ages. The Swoop system is commercially available in a select number of international markets. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Hyperfine Inc (HYPR) is currently priced at $0.7227, which is significantly below its 52-week high of $1.94, indicating potential upside. However, the RSI of 36.757 suggests the stock is currently oversold, and the company has a gross margin of 50.72%, indicating it can maintain profitability despite challenges. The main risk is the negative net income, which was -$9,298,000 in Q2 2026, showing ongoing financial struggles. Given these factors, while there is potential for recovery, the current financial instability suggests a hold rather than a buy at this time.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易